Dr Lohith Reddy has specialization with a fellowship from the European Society of Medical Oncology, St. Gallen, Switzerland, a fellowship on proton and carbon Ion, Pavia, Italy, a fellowship on proton therapy in Essen, Germany and another fellowship in SRS-SBRT, from Germany. He has been trained in high precision radiotherapy techniques like 3DCRT, IMRT and IGRT (Tomo-therapy), SART, SBRT or commonly known as Cyber-knife. Dr. Lohith also has special training in proton therapy, carbon ion therapy and brachytherapy. He heads the precision oncology initiative at HCG, dealing with Radiomics and Radio-genomics, to personalize cancer therapy.
He also has expertise in active precision oncology research in the imaging space and the usage of artificial intelligence in prognosticating and predicting the outcomes and side-effects of cancer by developing a concept of Radiomics and Radio-genomics and now heads an integrated team of doctors and engineers to develop Machine learning and deep learning algorithms in the oncology space.
Dr. Lohith is currently the Lead consultant for the Immune-Rad program to evaluate the combinations and developing protocols for immunotherapy combinations (Specific-PDL-1 and PD-1 Inhibitors& nonspecific cell based therapies such as T cells and dendritic cells) with Cyber-knife stereotactic radiosurgery & body radiotherapy.
Dr. Lohith was a nominated faculty at Harvard Business School for Accelerating precision medicine in oncology. He has presented in various national and international conferences and has scientific publications in indexed journals to his credit and has been an invited speaker at many multinational companies educating people about 4 P’s of cancer care-Prevention, Prediction, Precision, and Personalization and also involved in social causes to help cancer patients attain financial help for treatment via Indian cancer society& HCG foundation with a concept of crowd funding.
He is member of the European Society of Medical Oncology. He has attended seminars, worldwide. To name a few:
Reality Map Using Ki-Pcc Questionnare For Indian Scenario Based On Swiss – Romanian Study-Vienna, Austria
Trichellemmal Tumor of Scalp Treated By Electron Beam Therapy- Manchester, U.K.
G-68 Psma PET-CT in high risk prostate
Novel imaging with IGRT- Bethesda, USA
He also regularly conducts research and has received many Grant Awards. Some of them being:
HCG –SIEMENS-Auto-contouring project
TRAIN PROJECT (INDO-DUTCH)-MeITY
Few of the awards he has been presented with are:
Research Award from ESMO
Award for Research from Society of Neuro-oncology- Scottsdale, USA
Harvard Business School travel award-Boston-USA
His areas of specialization include Head & Neck Cancers, Breast Cancers, Prostate Cancers, Brain Tumors and innovative research in Radiomics and Radiogenomics.
- Throat cancer
- Salivary gland tumors
- Thyroid cancer
- Lymph nodes
- Head and neck cancer biopsy
- Head and neck cancer lump
- Head and neck cancer screening
- Head and neck cancer medication
- Head and neck cancer diagnosis
- Head and neck tumor
- Head and neck carcinoma
- Malignant Head and neck tumor
- Benign Head and neck tumor.
- Breast cyst.
- Breast cancer biopsy
- Breast cancer lump
- Breast cancer screening
- Breast cancer medication
- Breast cancer diagnosis
- Breast tumor
- Breast carcinoma
- Malignant Breast tumor
- Benign Breast tumor
- Consultant radiation oncologist, clinical director Radiomics and Radiogenomics,HCG,Dec 2015 – Present.
- Fellow Stereotactic Radiosurgery,University of Frankfurt,Jul 2016 – Jul 2016.
- Fellow carbon ion and proton therapy,Centro Nazionale di Adroterapia Oncologica (CNAO),Jul 2015 – Jul 2015
EducationM.B.B.S. | D.N.B.
- European Society of Medical Oncology(ESMO).